Modifications of sequential designs in bioequivalence trials

Publisher： John Wiley & Sons Inc

E-ISSN： 1539-1612|14|3|180-188

ISSN： 1539-1604

Source： PHARMACEUTICAL STATISTICS: THE JOURNAL OF APPLIED STATISTICS IN THE PHARMACEUTICAL INDUSTRY, Vol.14, Iss.3, 2015-05, pp. : 180-188

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Two‐stage designs for cross‐over bioequivalence trials

By  

STATISTICS IN MEDICINE, Vol. 34, Iss. 16, 2015-07 ,pp. : 2403-2416

John Wiley & Sons Inc

Access to resources Recommend Favorite

Start‐up designs for response‐adaptive randomization procedures with sequential estimation

By  

STATISTICS IN MEDICINE, Vol. 34, Iss. 21, 2015-09 ,pp. : 2958-2970

John Wiley & Sons Inc

Access to resources Recommend Favorite

Methods for proper handling of overrunning and underrunning in phase II designs for oncology trials

By  

STATISTICS IN MEDICINE, Vol. 34, Iss. 13, 2015-06 ,pp. : 2128-2137

John Wiley & Sons Inc

Access to resources Recommend Favorite

Bayesian optimal interval designs for phase I clinical trials

By  

JOURNAL OF THE ROYAL STATISTICAL SOCIETY: SERIES C (APPLIED STATISTICS), Vol. 64, Iss. 3, 2015-04 ,pp. : 507-523

John Wiley & Sons Inc

Access to resources Recommend Favorite

Relative efficiency of precision medicine designs for clinical trials with predictive biomarkers

By  

STATISTICS IN MEDICINE, Vol. 37, Iss. 5, 2018-02 ,pp. : 687-709

John Wiley & Sons Inc

Access to resources Recommend Favorite